Skip to main navigation Skip to search Skip to main content

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

  • Andrea CALCAGNO
  • , LORENA BAIETTO
  • , Francesco Giuseppe DE ROSA
  • , M. C. Tettoni
  • , V. Libanore
  • , R. Bertucci
  • , ANTONIO D'AVOLIO
  • , Giovanni DI PERRI

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)224-225
Number of pages2
JournalJournal of Antimicrobial Chemotherapy
Volume66
Issue number1
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AIDS-Related Opportunistic Infections
  • drug therapy
  • Africa
  • Western
  • Antifungal Agents
  • administration /&/ dosage/pharmacokinetics
  • Brain
  • microbiology/pathology/radiography
  • CD4 Lymphocyte Count
  • Central Nervous System Fungal Infections
  • Cerebrospinal Fluid
  • chemistry
  • HIV Infections
  • complications
  • Humans
  • Inhibitory Concentration 50
  • Magnetic Resonance Imaging
  • Mucormycosis
  • Triazoles

Cite this